Revenue: As of FY2025 Q3, the actual value is USD 9.351 M.EPS: As of FY2025 Q3, the actual value is USD 0.7.EBIT: As of FY2025 Q3, the actual value is USD 1.105 M.<h3>Segment Revenue</h3><ul><li>Income from Purchased Receivables under the EIR Method: $6,962,000 for the three months ended September 30, 2025, compared to $5,423,000 for the same period in 2024. For the nine months ended September 30, 2025, income was $19,039,000 compared to $9,985,000 in 2024.</li><li>Income from Purchased Receivables under the Cost Recovery Method: $1,857,000 for the three months ended September 30, 2025, compared to $1,040,000 for the same period in 2024. For the nine months ended September 30, 2025, income was $9,125,000 compared to $1,910,000 in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: $14,051,000 for the three months ended September 30, 2025, compared to a net loss of $17,243,000 for the same period in 2024. For the nine months ended September 30, 2025, net income was $25,609,000 compared to a net loss of $9,853,000 in 2024.</li><li>General and Administrative Expenses: $9,734,000 for the three months ended September 30, 2025, compared to $8,020,000 for the same period in 2024. For the nine months ended September 30, 2025, expenses were $25,682,000 compared to $27,485,000 in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $8,372,000 for the nine months ended September 30, 2025, compared to net cash used of $10,845,000 for the same period in 2024.</li><li>Net Cash Provided by Investing Activities: $31,539,000 for the nine months ended September 30, 2025, compared to $8,172,000 in 2024.</li><li>Net Cash Used in Financing Activities: $15,774,000 for the nine months ended September 30, 2025, compared to $10,061,000 in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Gains on Acquisitions: $18,004,000 for the three and nine months ended September 30, 2025, compared to $19,316,000 for the nine months ended September 30, 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company expects income related to VABYSMO to increase in future periods based on projected sales estimates. Additionally, income from OJEMDA is expected to increase based on projections reported by DayOne.</li><li>Non-Core Business: The company plans to acquire LAVA and Mural through tender offers, with the acquisitions expected to close in the near future. These acquisitions are part of the company’s strategy to expand its portfolio of economic rights to future potential milestone and royalty payments.</li></ul>

XOMA Corp Pref Share 8.625 Perp 12/15/21 | 10-Q: FY2025 Q3 Revenue: USD 9.351 M